Showing results (1-10 of 504) with videos related to
Sort By:
Pageof 51
The Lancet. Neurology|June 21, 2011
Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseasesAntonio Uccelli, Alice Laroni, Mark S FreedmanMultiple Sclerosis (Houndmills, Basingstoke, England)|November 6, 2012
Mesenchymal stem cells as treatment for MS - progress to dateAntonio Uccelli, Alice Laroni, Mark S FreedmanJournal of Clinical Medicine|May 17, 2020
CD56bright Natural Killer Cells: A Possible Biomarker of Different Treatments in Multiple SclerosisAlice Laroni, Antonio UccelliImmunology Letters|August 23, 2015
Mesenchymal stem cells for the treatment of neurological diseases: Immunoregulation beyond neuroprotectionAlice Laroni, Nicole Kerlero de Rosbo, Antonio UccelliMultiple Sclerosis (Houndmills, Basingstoke, England)|September 3, 2025
Immunosenescence in multiple sclerosis: New insights and clinical implicationsAlice Laroni, Tiziana Vigo, Matilde Inglese, et al.Best Practice & Research. Clinical Haematology|March 15, 2011
Neuroprotective features of mesenchymal stem cellsAntonio Uccelli, Federica Benvenuto, Alice Laroni, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|November 18, 2020
COVID-19 in patients with multiple sclerosis undergoing disease-modifying treatmentsAlice Laroni, Irene Schiavetti, Maria Pia Sormani, et al.Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|April 13, 2013
Towards clinical application of mesenchymal stem cells for treatment of neurological diseases of the central nervous systemAlice Laroni, Giovanni Novi, Nicole Kerlero de Rosbo, et al.Multiple Sclerosis and Related Disorders|January 25, 2022
High or increasing serum NfL is predictive of impending multiple sclerosis relapsesSimon Thebault, Michael Reaume, Ruth Ann Marrie, et al.Immunological Reviews|June 26, 2012
T-cell trafficking in the central nervous systemFederica Sallusto, Daniela Impellizzieri, Camilla Basso, et al.Pageof 51